{
    "2018-09-05": [
        [
            {
                "time": "2023-10-15",
                "original_text": "Analyzing Alexion Pharmaceuticals’ Operational Performance",
                "features": {
                    "keywords": [
                        "Alexion",
                        "Pharmaceuticals",
                        "Operational Performance"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-15",
                "original_text": "Alexion’s Top Line Continues to Expand Significantly",
                "features": {
                    "keywords": [
                        "Alexion",
                        "Top Line",
                        "Expand",
                        "Significantly"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-15",
                "original_text": "Abbott Laboratories Is a 'Forever' Stock",
                "features": {
                    "keywords": [
                        "Abbott Laboratories",
                        "Forever Stock"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-15",
                "original_text": "Do Abiomed’s Valuations Look Attractive?",
                "features": {
                    "keywords": [
                        "Abiomed",
                        "Valuations",
                        "Attractive"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}